Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biotech Startups Trading IPO Filings For Selling Block – BIO Panel

Executive Summary

The goal of a biotech startup appears to have shifted away from a focus on entering the public market through an IPO in favor of building the company to become an acquisition target

You may also be interested in...



Novartis Gains Hepatitis Market Access Through Idenix Majority Stake

Novartis is adding three novel hepatitis products to its antiviral pipeline through a 51% stake in the privately held biotech company Idenix

Novartis Gains Hepatitis Market Access Through Idenix Majority Stake

Novartis is adding three novel hepatitis products to its antiviral pipeline through a 51% stake in the privately held biotech company Idenix

Dendreon/Corvas merger in peril?

Several large Corvas shareholders oppose acquisition by Dendreon, maintaining that deal does not fairly value company. One proposal would liquidate the company ("The Pink Sheet" March 3, p. 25)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel